Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Hyperscale Data Inc., 3 years.
Hyperscale Data Inc.
Director · Chief Executive Officer
Alzamend Neuro Inc.
Director
Chief executive roles
Hyperscale Data Inc.
· Chief Executive Officer
Dates unknown
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alzamend Neuro Inc. April 17, 202684.4%
-
Hyperscale Data Inc. December 29, 202598.2%
-
Alzamend Neuro Inc. April 25, 202596.0%
-
Hyperscale Data Inc. June 28, 202471.9%
-
Alzamend Neuro Inc. May 1, 202489.7%
-
Hyperscale Data Inc. January 12, 202464.9%
-
Alzamend Neuro Inc. April 26, 202396.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 29, 2026 | Hyperscale Data Inc. | Open-market purchase | +100,000 | $0.17 | $16,800 |
| Sep 16, 2026 | Hyperscale Data Inc. | Open-market purchase | +1,000 | $18.00 | $18,000 |
| Sep 8, 2026 | Hyperscale Data Inc. | Open-market purchase | +60,000 | $0.19 | $11,220 |
| Sep 4, 2026 | Hyperscale Data Inc. | Open-market purchase | +100,000 | $0.20 | $20,000 |
| Sep 2, 2026 | Hyperscale Data Inc. | Open-market purchase | +100,000 | $0.20 | $19,990 |
| Jun 29, 2026 | Hyperscale Data Inc. | Open-market purchase | +5,000 | $19.00 | $95,000 |
| Jun 11, 2026 | Hyperscale Data Inc. | Open-market purchase | +200,000 | $0.17 | $34,000 |
| Dec 19, 2025 | Alzamend Neuro Inc. | Open-market sale | −3,333 | $2.12 | $7,066 |
| Mar 26, 2025 | Alzamend Neuro Inc. | Open-market purchase | +3,334 | $0.99 | $3,301 |
| Mar 20, 2025 | Alzamend Neuro Inc. | Open-market purchase | +5,000 | $0.98 | $4,900 |
| Mar 18, 2025 | Alzamend Neuro Inc. | Option exercise | +10,000 | $0.06 | $600 |
| Mar 18, 2025 | Alzamend Neuro Inc. | Open-market purchase | +5,000 | $0.97 | $4,850 |
| Dec 30, 2024 | Hyperscale Data Inc. | Open-market sale | −2 | $5.21 | $10 |
| Feb 24, 2023 | Alzamend Neuro Inc. | Option exercise | +500,000 | — | — |
| Jan 9, 2023 | Hyperscale Data Inc. | Option exercise | +300,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.